{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:04:11Z","timestamp":1785074651290,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["107739"],"award-info":[{"award-number":["107739"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jinorgbio.2026.113399","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:10:13Z","timestamp":1783177813000},"page":"113399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bimetallic Anilinopyridinate ruthenium(II,III) complexes: Synthesis, characterisation, and in vitro selective cytotoxicity towards MCF-7 breast cancer cells"],"prefix":"10.1016","volume":"283","author":[{"given":"Thato T.","family":"Medupe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirvashi D.","family":"Autar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyabonga","family":"Ngubane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2026.113399_bb0005","first-page":"1","article-title":"Current metallodrugs success in breast cancer treatment","volume":"1","author":"Thake","year":"2023","journal-title":"Glob. J. Clin. Med. Med. Res."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0010","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ardp.200600151","article-title":"Non platinum metal complexes as anti-cancer drugs","volume":"340","author":"Ott","year":"2007","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0020","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode","volume":"205","author":"Rosenberg","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/jcp.35.11.1298-d","article-title":"Recent results in cancer research","volume":"35","author":"Kay","year":"1982","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0030","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0959-8049(98)00224-X","article-title":"Clinical development of platinum complexes in cancer therapy: an historical perspective and an update","volume":"34","author":"Lebwohl","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2165\/00003495-198937020-00005","article-title":"Carboplatin","volume":"37","author":"Wagstaff","year":"1989","journal-title":"Drugs"},{"issue":"1990","key":"10.1016\/j.jinorgbio.2026.113399_bb0040","first-page":"321","article-title":"Clinical results of carboplatin in the treatment of malignant tumors","volume":"12","author":"Liu Za Zhi","year":"1989","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0045","first-page":"1","article-title":"Oxaliplatin","volume":"38","author":"L\u00e9vi","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0050","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612033454180","article-title":"Recent developments in the field of tumor-inhibiting metal complexes","volume":"9","author":"Galanski","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0055","series-title":"Rev. Physiol. Biochem. Pharmacol.","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10254-002-0001-x","article-title":"Tumour-Inhibiting Platinum Complexes\u2014State of the Art and Future Perspectives","author":"Jakupec","year":"2003"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0060","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2174\/0929867054637626","article-title":"Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches","volume":"12","author":"Galanski","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0065","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1039\/c0dt00292e","article-title":"The status of platinum anticancer drugs in the clinic and in clinical trials","volume":"39","author":"Wheate","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003495-200059004-00003","article-title":"Clinical pharmacokinetics and administration of established platinum drugs","volume":"59","author":"O\u2019Dwyer","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-200059004-00002","article-title":"Clinical perspectives on platinum resistance","volume":"59","author":"Giaccone","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0085","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0090","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0095","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","article-title":"Metallodrugs in medicinal inorganic chemistry","volume":"114","author":"Mjos","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejmech.2017.12.087","article-title":"An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT\/mTOR pathway","volume":"145","author":"Tang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejmech.2017.11.091","article-title":"Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex","volume":"145","author":"Yi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ejmech.2018.04.013","article-title":"Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules","volume":"151","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cbpa.2007.11.013","article-title":"New trends for metal complexes with anticancer activity","volume":"12","author":"Bruijnincx","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0120","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1007\/s10904-020-01618-2","article-title":"Bipyrazole based novel bimetallic \u03bc-oxo bridged Au(III) complexes as potent DNA intercalative, genotoxic, anticancer, antibacterial and cytotoxic agents","volume":"30","author":"Kanthecha","year":"2020","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0125","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/molecules28062671","article-title":"Cytotoxicity evaluation of unmodified paddlewheel dirhodium(II,II)-acetate\/\u2212formamidinate complexes and their axially modified low-valent metallodendrimers","volume":"28","author":"de Doncker","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0130","first-page":"119","article-title":"Metal-based antitumor compounds: beyond cisplatin, future","volume":"11","author":"Simpson","year":"2019","journal-title":"Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0010-8545(02)00025-5","article-title":"Ruthenium metallopharmaceuticals","volume":"232","author":"Clarke","year":"2002","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jorganchem.2019.04.002","article-title":"Modulation of the solubility properties of arene ruthenium complexes bearing stannyl ligands as potential anti-cancer agents","volume":"891","author":"Berg","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drup.2006.05.002","article-title":"DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity","volume":"9","author":"Brabec","year":"2006","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0150","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1021\/cr9804238","article-title":"Non-platinum chemotherapeutic metallopharmaceuticals","volume":"99","author":"Clarke","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0155","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1021\/acs.organomet.5b00041","article-title":"Strong in vitro cytotoxic potential of new ruthenium\u2013cymene complexes","volume":"34","author":"Nikoli\u0107","year":"2015","journal-title":"Organometallics"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jinorgbio.2006.02.013","article-title":"From bench to bedside \u2013 preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)","volume":"100","author":"Hartinger","year":"2006","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0165","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2174\/1568026043387421","article-title":"Ruthenium antimetastatic agents","volume":"4","author":"Alessio","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0170","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1039\/C3SC53243G","article-title":"NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application","volume":"5","author":"Trondl","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0175","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3390\/molecules24101995","article-title":"NAMI-A and KP1019\/1339, two iconic ruthenium anticancer drug candidates face-to-face: a case story in medicinal inorganic chemistry","volume":"24","author":"Alessio","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0180","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/biomedicines14051028","article-title":"Heterometallic multinuclear ruthenium complexes as cytotoxic agents","volume":"14","author":"Kostova","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0185","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/ejic.201900375","article-title":"Heterometallic multinuclear complexes as anti-cancer agents-an overview of recent developments","volume":"2019","author":"van Niekerk","year":"2019","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0190","first-page":"889","article-title":"Cytotoxicity of a series of water-soluble mixed valent diruthenium tetracarboxylates","volume":"22","author":"Van Rensburg","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jinorgbio.2016.10.003","article-title":"Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration","volume":"165","author":"Hanif-Ur-Rehman","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0200","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.poly.2007.12.011","article-title":"Diruthenium(II,III) complexes of ibuprofen, aspirin, naproxen and indomethacin non-steroidal anti-inflammatory drugs: synthesis, characterization and their effects on tumor-cell proliferation","volume":"27","author":"Ribeiro","year":"2008","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0162-0134(00)00106-9","article-title":"Synthesis and characterization of a diruthenium\u2013ibuprofenato complex","volume":"81","author":"Andrade","year":"2000","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0210","first-page":"312","article-title":"Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy, anticancer. Agents","volume":"10","author":"de Oliveira Silva","year":"2010","journal-title":"Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cbf.1626","article-title":"The novel ruthenium\u2014 \u03b3 -linolenic complex [Ru2(aGLA)4Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro","volume":"28","author":"Ribeiro","year":"2010","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0220","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jinorgbio.2010.04.011","article-title":"Inhibition of C6 rat glioma proliferation by [Ru2Cl(Ibp)4] depends on changes in p21, p27, Bax\/Bcl2 ratio and mitochondrial membrane potential","volume":"104","author":"Benadiba","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0225","doi-asserted-by":"crossref","first-page":"110984","DOI":"10.1016\/j.jinorgbio.2019.110984","article-title":"Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells","volume":"205","author":"Alves","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0230","series-title":"Profiles Drug Subst. Excipients Relat. Methodol.","first-page":"273","article-title":"Validation of in-vitro bioassay methods: Application in herbal drug research","author":"Indrayanto","year":"2021"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0235","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1039\/C6DT04328C","article-title":"Anilinopyridinate-supported Ru2x+ (x = 5 or 6) paddlewheel complexes with labile axial ligands","volume":"46","author":"Corcos","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0240","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1021\/ic034722d","article-title":"Solvent effects on the electrochemistry and Spectroelectrochemistry of diruthenium complexes. Studies of Ru2(L)4Cl where L = 2-CH3 ap, 2-fap, and 2,4,6-F3ap, and ap is the 2-Anilinopyridinate anion","volume":"42","author":"Kadish","year":"2003","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0245","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1039\/c2dt32715e","article-title":"Synthesis, structure, and electrochemical characterization of a mixed-ligand diruthenium(III,II) complex with an unusual arrangement of the bridging ligands","volume":"42","author":"Ngubane","year":"2013","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0250","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/acs.inorgchem.9b02838","article-title":"Synthesis, structural and physicochemical properties of water-soluble mixed-ligand diruthenium complexes containing anilinopyridinate bridging ligands","volume":"59","author":"Osterloh","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0255","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ccr.2004.06.016","article-title":"Recent developments in the synthesis and properties of diruthenium tetracarboxylates","volume":"248","author":"Aquino","year":"2004","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0260","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1039\/D3QI00157A","article-title":"Diruthenium(II, III) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties","volume":"10","author":"Tolbatov","year":"2023","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0265","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1021\/ic50199a052","article-title":"Structural studies of some multiply bonded diruthenium tetracarboxylate compounds","volume":"18","author":"Bino","year":"1979","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0270","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/0022-1902(66)80118-5","article-title":"New ruthenium carboxylate complexes","volume":"28","author":"Stephenson","year":"1966","journal-title":"J. Inorg. Nucl. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0275","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1248\/cpb.29.3706","article-title":"Reaction of aromatic N-oxides with dipolarophiles. IV. Factors affecting the 1,3-cycloaddition of pyridine 1-oxide with phenyl isocyanates","volume":"29","author":"Hisano","year":"1981","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0280","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1021\/ic001315i","article-title":"Syntheses, structural determination, and electrochemistry of Ru2(fap)4Cl and Ru2(fap)4NOCl","volume":"40","author":"Bear","year":"2001","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. Sect. A Found. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0290","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C Struct. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1472-7862(02)00030-8","article-title":"X-seed \u2014 a software tool for supramolecular crystallography","volume":"1","author":"Barbour","year":"2001","journal-title":"J. Supramol. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/cg020063o","article-title":"Molecular graphics: from science to art","volume":"3","author":"Atwood","year":"2003","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0305","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1107\/S1600576720007438","article-title":"X-seed 4: updates to a program for small-molecule supramolecular crystallography","volume":"53","author":"Barbour","year":"2020","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0310","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1107\/S0021889806051557","article-title":"DRAWxtl, an open-source computer program to produce crystal structure drawings","volume":"40","author":"Finger","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0315","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0325","first-page":"1","article-title":"Craig plot 2.0: an interactive navigation in the substituent bioisosteric space","volume":"12","author":"Ertl","year":"2020","journal-title":"J. Chemother."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0330","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1021\/acs.joc.5c00426","article-title":"Typical electron-withdrawing groups are ortho, meta-directors rather than meta-directors in electrophilic aromatic substitution","volume":"90","author":"Rablen","year":"2025","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.inoche.2003.09.012","article-title":"Dicarboxylato-bridged diruthenium units in two different oxidation states: the first step towards the synthesis of Creutz\u2013Taube analogs with dinuclear Ru2+ species","volume":"7","author":"Angaridis","year":"2004","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0340","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/ic00287a025","article-title":"Electronic spectra of Ru2(carboxylate)4+ complexes. Higher energy electronic excited states","volume":"27","author":"Miskowski","year":"1988","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/ic50071a001","article-title":"Structure of tetra-n-butyratodiruthenium chloride, a compound with a strong metal-metal bond","volume":"8","author":"Bennett","year":"1969","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0350","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/ja00198a031","article-title":"Chemistry, structure and bonding in diruthenium(II) tetracarboxylates","volume":"111","author":"Cotton","year":"1989","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0355","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1021\/ic060267k","article-title":"Synthesis, characterization, and electrochemistry of diruthenium(III,II) and monoruthenium(III) complexes containing pyridyl-substituted 2-anilinopyridinate ligands","volume":"45","author":"Kadish","year":"2006","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0360","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/ic00196a011","article-title":"Syntheses, molecular structures, and properties of two polar diruthenium(II,III) complexes of 2-hydroxypyridine and 2-anilinopyridine","volume":"24","author":"Chakravarty","year":"1985","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0365","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1039\/jr9590002003","article-title":"The determination of the paramagnetic susceptibility of substances in solution by nuclear magnetic resonance","author":"Evans","year":"1959","journal-title":"J. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0370","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1021\/ic001245f","article-title":"Synthesis, electrochemistry, and spectroscopic characterization of bis-dirhodium complexes linked by axial ligands","volume":"40","author":"Bear","year":"2001","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0375","doi-asserted-by":"crossref","first-page":"213706","DOI":"10.1016\/j.ccr.2020.213706","article-title":"Electrochemistry of metal-metal bonded diruthenium complexes","volume":"434","author":"Van Caemelbecke","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0380","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.molstruc.2013.10.072","article-title":"Coordination of weakly binding anions to [Ru2(\u03bc-O2CCH3)4]+ in aqueous solution","volume":"1058","author":"Dunlop","year":"2014","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0385","doi-asserted-by":"crossref","first-page":"120684","DOI":"10.1016\/j.ica.2021.120684","article-title":"Reaction of dirhodium and diruthenium paddlewheel tetraacetate complexes with nucleophilic protein sites: a computational study","volume":"530","author":"Tolbatov","year":"2022","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0390","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ejic.201600908","article-title":"Redox-active metal complexes for anticancer therapy","volume":"2017","author":"Zhang","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0395","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12906-016-1212-z","article-title":"Selective cytotoxicity of a Vietnamese traditional formula, Nam Dia long, against MCF-7 cells by synergistic effects","volume":"16","author":"Nguyen","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0400","first-page":"2993","article-title":"Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells","volume":"29","author":"Badisa","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0405","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0410","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/cdd.2009.44","article-title":"Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes","volume":"16","author":"Galluzzi","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0415","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mrrev.2013.02.001","article-title":"gH2AX as a marker of DNA double strand breaks and genomic instability in human population studies","volume":"753","author":"Valdiglesias","year":"2013","journal-title":"Mutat. Res. Mutat. Res."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0420","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1093\/nar\/gkn550","article-title":"G-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin","volume":"36","author":"Kinner","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0425","doi-asserted-by":"crossref","first-page":"22932","DOI":"10.1074\/jbc.274.33.22932","article-title":"Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis","volume":"274","author":"Boulares","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113399_bb0430","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archsurg.1982.01380250019004","article-title":"Clinical correlations with drug sensitivities in the clonogenic assay","volume":"117","author":"Mann","year":"1982","journal-title":"Arch. Surg."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426001881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426001881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:52:33Z","timestamp":1785073953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013426001881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":86,"alternative-id":["S0162013426001881"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113399","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bimetallic Anilinopyridinate ruthenium(II,III) complexes: Synthesis, characterisation, and in vitro selective cytotoxicity towards MCF-7 breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113399"}}